image: Inhibition of the NFkB pathway by depletion of one of tis components, IKK2 (represented in red) in glioblastoma tumor cells (shown in green and yellow) resulted in slower tumor growth. This material relates to a paper that appeared in the Jan. 8, 2016, issue of Science, published by AAAS. The paper, by D. Friedmann-Morvinski of The Salk Institute for Biological Studies in La Jolla, Calif., and colleagues was titled, "Targeting NF-κB in glioblastoma: A therapeutic approach." view more
Credit: [Credit: Courtesy of Dinorah Friedmann-Morvinski]